Skip to content

Clinical trials

Phase 3 Diabetes Mellitus, Type 2 trials in South Africa

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Phase 3 Country / region: South Africa Clear all

139 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20031
20042
20054
200614
20072
200813
200912
201018
20117
20129
201311
201410
20153
20164
20175
20182
20193
20213
20223
20232
20244
20251
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed121
Terminated12
Recruiting5
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S44
AstraZeneca24
Takeda17
Sanofi10
Eli Lilly and Company8
GlaxoSmithKline7
Boehringer Ingelheim6
Hoffmann-La Roche5
Janssen Research & Development, LLC5
Gilead Sciences3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 2139
Diabetes Mellitus49
Glucose Metabolism Disorders11
Dyslipidemias8
Renal Insufficiency, Chronic8
Cardiovascular Diseases5
Hyperglycemia4
Diabetic Nephropathies3
Glucose Intolerance3
Metabolic Diseases3

Trials

Showing 1 to 25 of 139. Each trial links to its page on Pharma Observatory.

39 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.